A, M., S, G., & NB, M. (2017). Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa. Clinical pharmacokinetics, 56(9), 999. https://doi.org/10.1007/s40262-017-0511-y
Chicago Style (17th ed.) CitationA, Mittur, Gupta S, and Modi NB. "Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa." Clinical Pharmacokinetics 56, no. 9 (2017): 999. https://doi.org/10.1007/s40262-017-0511-y.
MLA (9th ed.) CitationA, Mittur, et al. "Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa." Clinical Pharmacokinetics, vol. 56, no. 9, 2017, p. 999, https://doi.org/10.1007/s40262-017-0511-y.
Warning: These citations may not always be 100% accurate.